United Kingdom (STL.News) The Chair of the Vaccine Taskforce, Kate Bingham, has placed the UK at the leading edge of the international effort to fight the Covid-19 pandemic through the development of clinically safe and effective vaccines.
An article published this week in the Sunday Times has made a series of allegations and insinuations about Kate Bingham and her role. Inaccuracies are being addressed with The Sunday Times.
A presentation she gave to a women’s conference in the United States was the focus of the article. The fact of her appearance and the content of her presentation received approval from officials at the Department for Business, Energy, and Industrial Strategy in line with the process governing such engagements. Kate Bingham focused on publicly available information and said little that expert delegates at the conference could not deduce themselves.
Kate Bingham is uniquely qualified for the role of Chair, having worked in the biotech and life sciences sectors for 30 years. While not specifically a vaccines expert, she is a proven drugs discovery expert with superb deal-making skills and an excellent global reputation, recently appearing alongside Bill Gates at the Gates Grand Challenge Conference. She is well known and highly rated by multinational pharmaceutical and vaccine companies. She has a first class degree in Biochemistry from the University of Oxford, an MBA from Harvard Business School (Baker Scholar) and is a board member of the Francis Crick Institute. Her investments have led to the launch of six drugs for the treatment of patients with inflammatory and autoimmune disease and cancer. Kate stepped back from her full-time role as Managing Partner at SV Health Investors to take on this role as Chair of the Taskforce, for which she is unpaid.
Under her leadership of the Vaccine Taskforce, in the past six months: